קם-רהו די I.M

Šalis: Izraelis

kalba: hebrajų

Šaltinis: Ministry of Health

Veiklioji medžiaga:

ANTI-D IMMUNOGLOBULINS

Prieinama:

KAMADA LTD, ISRAEL

ATC kodas:

J06BB01

Vaisto forma:

תמיסה להזרקה

Sudėtis:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Vartojimo būdas:

תוך-שרירי

Recepto tipas:

מרשם נדרש

Pagaminta:

KAMADA LTD, ISRAEL

Farmakoterapinė grupė:

ANTI-D (RH) IMMUNOGLOBULIN

Gydymo sritis:

ANTI-D (RH) IMMUNOGLOBULIN

Terapinės indikacijos:

Pregnancy/other obstetric conditions, Suppression of Rh immunization in non-sensitized Rh0 (D) negative women delivering an Rh0 positive baby or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. Kam Rh0 -D IM should be given within 72 hours of the event. It may be given even after up to one month although efficacy may be somewhat reduced.Transfusion: Suppression of Rh isoimmunization in Rh0 (D) antigen-negative patients transfused with Rh0 (D) antigen-positive RBCs of blood components containing Rh0 (D) antigen-positive RBCs . Initate treatment within 72 hours of exposure.

Leidimo data:

2022-01-31